DE3855947T2 - Peptide mit den immunologischen Eigenschaften von HIV-2 - Google Patents
Peptide mit den immunologischen Eigenschaften von HIV-2Info
- Publication number
- DE3855947T2 DE3855947T2 DE3855947T DE3855947T DE3855947T2 DE 3855947 T2 DE3855947 T2 DE 3855947T2 DE 3855947 T DE3855947 T DE 3855947T DE 3855947 T DE3855947 T DE 3855947T DE 3855947 T2 DE3855947 T2 DE 3855947T2
- Authority
- DE
- Germany
- Prior art keywords
- hiv
- peptides
- immunological properties
- peptidic
- siv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000031886 HIV Infections Diseases 0.000 title abstract 4
- 241000713340 Human immunodeficiency virus 2 Species 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000001900 immune effect Effects 0.000 title abstract 2
- 101710121417 Envelope glycoprotein Proteins 0.000 abstract 2
- 102100021696 Syncytin-1 Human genes 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
- G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/003,764 US5051496A (en) | 1986-01-22 | 1987-01-16 | Peptides related to human immunodeficiency virus II (HIV-2) |
FR8701739A FR2610632B1 (fr) | 1987-02-11 | 1987-02-11 | Peptides caracteristiques des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida |
FR8705398A FR2614025B1 (fr) | 1987-04-15 | 1987-04-15 | Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3855947D1 DE3855947D1 (de) | 1997-07-31 |
DE3855947T2 true DE3855947T2 (de) | 1997-12-11 |
Family
ID=27251436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3855947T Expired - Lifetime DE3855947T2 (de) | 1987-01-16 | 1988-01-15 | Peptide mit den immunologischen Eigenschaften von HIV-2 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0283327B1 (de) |
JP (5) | JP2948823B2 (de) |
AT (1) | ATE154808T1 (de) |
AU (1) | AU608294B2 (de) |
DE (1) | DE3855947T2 (de) |
DK (1) | DK174705B1 (de) |
ES (1) | ES2104556T3 (de) |
GR (1) | GR3024823T3 (de) |
WO (1) | WO1988005440A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19908766C2 (de) * | 1999-02-19 | 2001-02-15 | Ulrich Schubert | Verwendung synthetischer Vpr-Peptide des Humanen Immundefizienzvirus Typ 1 (HIV-1) zur Entwicklung von therapeutischen und diagnostischen Reagenzien |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8701628D0 (sv) * | 1987-04-16 | 1987-04-16 | Erling Norrby | Medel for analys mm |
AU2914889A (en) * | 1987-08-28 | 1989-04-17 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
US5780038A (en) * | 1987-11-16 | 1998-07-14 | Roche Diagnostic Systems, Inc. | HIV-2 envelope polypeptides |
EP0316695B1 (de) * | 1987-11-16 | 1993-03-31 | F. Hoffmann-La Roche Ag | Rekombinante HIV-2 Polypeptide |
AU3063389A (en) * | 1988-01-08 | 1989-08-01 | Dpz Deutsches Primatenzentrum Gesellschaft M.B.H. | Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions |
FR2632644B1 (fr) * | 1988-06-10 | 1994-11-04 | Pasteur Institut | Antigenes precurseurs des glycoproteines d'enveloppe d'un retrovirus humain hiv-2 et antigenes presentant une parente immunologique avec ces derniers. preparation de ces antigenes. application au diagnostic |
JP3093763B2 (ja) * | 1988-06-09 | 2000-10-03 | インスティチュート・パスツール | ヒトレトロウィルスhiv―2の外被糖タンパク質の前駆抗原及びそれと免疫学的同族性をもつ抗原、ならびにこれらの抗原の調製方法及び診断への応用 |
EP0346022B1 (de) * | 1988-06-10 | 1996-02-14 | United Biomedical, Inc. | Peptidfragmente von HIV |
IL90553A0 (en) * | 1988-06-13 | 1990-01-18 | Us Health | Protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses |
FR2635532B1 (fr) * | 1988-07-29 | 1992-05-22 | Pasteur Institut | Particules hbsag recombinantes hybrides : caracteristiques morphologiques de l'antigene hbsag contenant 1 sequence immunogene induisant des anticorps neutralisants diriges contre hiv ou susceptible d'etre reconnue par de tels anticorps; sequences nucleotidiques codant pour de telles particules; vaccins les contenant |
EP0362927A3 (de) * | 1988-10-06 | 1990-11-14 | Akzo N.V. | Mit HIV-Antikörpern immunochemisch reaktive synthetische Polypeptide |
CA2003383A1 (en) * | 1988-11-23 | 1990-05-23 | Sushil G. Devare | Synthetic dna derived recombinant hiv antigens |
US5260189A (en) * | 1988-12-20 | 1993-11-09 | Immunodiagnostics, Inc. | Synthetic HIV-like peptides their compositions and uses |
FR2646854A1 (fr) * | 1989-05-12 | 1990-11-16 | Pasteur Institut | Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 antigenes presentant avec eux une parente immunologique |
DE69026569T2 (de) * | 1989-05-12 | 1996-09-05 | Pasteur Institut | Antigene eines transmembranen hüllenglycoproteins eines menschlichen retrovirus des typs hiv-2 und immunologisch verwandte antigene |
EP0682951B1 (de) * | 1989-05-31 | 1997-12-17 | Institut Pasteur | Ein aus dem Hüll-Glycoprotein des HIV-2-EHO-Retrovirus bestehendes gereinigtes Antigen enthaltende immunologische Zusammensetzungen |
ATE466111T1 (de) | 1989-06-02 | 2010-05-15 | Pasteur Institut | Nukleotidsequenzen des genoms von retroviren des typs hiv-1, hiv-2 und siv und deren anwendungen, insbesondere zur amplifikation von genomen dieser retroviren und für die in-vitro-diagnostik von durch diese viren ausgelösten infektionen |
FR2647809B1 (fr) * | 1989-06-02 | 1991-09-20 | Pasteur Institut | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus |
FR2647810B1 (fr) * | 1989-06-02 | 1994-07-22 | Pasteur Institut | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus |
US7022814B1 (en) | 1992-01-21 | 2006-04-04 | Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale | Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
DE3934366A1 (de) * | 1989-10-14 | 1991-04-18 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum |
US6248574B1 (en) * | 1989-12-13 | 2001-06-19 | Avigdor Shaffermann | Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides |
FR2657016B1 (fr) * | 1990-01-16 | 1995-08-25 | Clonatec Sa | Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida. |
DE69129207T2 (de) * | 1990-01-16 | 1998-10-08 | Orgenics Ltd | Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS |
DE4002636A1 (de) * | 1990-01-30 | 1991-08-01 | Boehringer Mannheim Gmbh | Expression von hiv1- und 2-polypeptiden und deren verwendung |
EP0594638A1 (de) * | 1991-06-03 | 1994-05-04 | Syntello Vaccine Development Ab | Peptide zur induktion der t-zell aktivierung gegen hiv-1 |
EP0726962B1 (de) | 1991-12-23 | 2006-06-07 | Chiron Corporation | Sätze von HIV Sonden für Solution Sandwich Hybridationsverfahren |
JPH0748276A (ja) * | 1992-03-26 | 1995-02-21 | Inmeru:Kk | Hiv感染症予防ワクチンおよびその製造法 |
US6479055B1 (en) | 1993-06-07 | 2002-11-12 | Trimeris, Inc. | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
ES2286854T3 (es) * | 1997-08-01 | 2007-12-01 | Bio-Rad Laboratories, Inc. | Antigenos sinteticos para la deteccion de anticuerpos que tienen inmunoreactividad frente al virus hiv. |
CA2562385A1 (en) * | 2004-04-09 | 2005-10-20 | University Of Manitoba | Identification of the precise amino acid sequence of the epitope recognized by the potent neutralizing human anti-hiv-1 monoclonal antibody igg1b12 |
EP2420248A1 (de) * | 2004-08-17 | 2012-02-22 | Institut Gustave Roussy | Mutiertes HIV-NEF zur Immunitätsmodulation |
WO2007141650A2 (en) * | 2006-01-17 | 2007-12-13 | Instituto De Medicina Molecular | Compositions and methods for diagnosing hiv-2 infection |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE64006B1 (en) * | 1984-10-18 | 1995-06-28 | Pasteur Institut | Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus |
EP0187041B1 (de) * | 1984-12-24 | 1996-05-15 | Genentech, Inc. | Fusionen von AIDS-verwandten Polypeptiden |
FI861626A (fi) * | 1985-04-19 | 1986-10-20 | Hoffmann La Roche | Foervaervat immunbristsyndrom (aids) -relaterat viralt rekombinant hoeljeprotein samt ett testfoerfarande foer aids. |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
DE3533440A1 (de) * | 1985-09-19 | 1987-03-26 | Hoechst Ag | N-substituierte 3,4,5,6-tetrahydrophthalimide, verfahren zu ihrer herstellung sowie ihre verwendung im pflanzenschutz |
GR862412B (en) * | 1985-09-25 | 1987-01-23 | Oncogen | Vaccines and immuinoassays for acquired immune deficiency syndrome |
ES2150897T3 (es) * | 1986-01-22 | 2000-12-16 | Pasteur Institut | Procedimiento de fabricacion recombinante de las proteinas derivadas de hiv-2 y cultivo celular que expresa proteinas de hiv-2. |
FR2593189B1 (fr) * | 1986-01-22 | 1989-10-20 | Pasteur Institut | Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida |
EP0269520A3 (de) * | 1986-11-21 | 1988-08-24 | Institut Pasteur | Zum Hervorrufen von AIDS geeignetes Retrovirus vom HIV-2-Typ sowie seine Antigen- und Nukleinsäurebestandteile |
JP3105581B2 (ja) * | 1991-07-03 | 2000-11-06 | 内橋エステック株式会社 | 面状温度ヒュ−ズ |
JPH0833969A (ja) * | 1994-07-22 | 1996-02-06 | Toyota Motor Corp | 加圧鋳造方法 |
-
1988
- 1988-01-15 AT AT88400084T patent/ATE154808T1/de not_active IP Right Cessation
- 1988-01-15 JP JP63501472A patent/JP2948823B2/ja not_active Expired - Lifetime
- 1988-01-15 EP EP88400084A patent/EP0283327B1/de not_active Expired - Lifetime
- 1988-01-15 DE DE3855947T patent/DE3855947T2/de not_active Expired - Lifetime
- 1988-01-15 ES ES88400084T patent/ES2104556T3/es not_active Expired - Lifetime
- 1988-01-15 AU AU12250/88A patent/AU608294B2/en not_active Expired
- 1988-01-15 WO PCT/FR1988/000025 patent/WO1988005440A1/fr unknown
- 1988-09-15 DK DK198805133A patent/DK174705B1/da not_active IP Right Cessation
-
1995
- 1995-04-19 JP JP7117839A patent/JP2862810B2/ja not_active Expired - Lifetime
-
1997
- 1997-09-24 GR GR970402458T patent/GR3024823T3/el unknown
-
1999
- 1999-04-06 JP JP11099449A patent/JPH11322792A/ja active Pending
-
2001
- 2001-04-27 JP JP2001133477A patent/JP2002030099A/ja active Pending
-
2003
- 2003-05-19 JP JP2003140638A patent/JP2004002421A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19908766C2 (de) * | 1999-02-19 | 2001-02-15 | Ulrich Schubert | Verwendung synthetischer Vpr-Peptide des Humanen Immundefizienzvirus Typ 1 (HIV-1) zur Entwicklung von therapeutischen und diagnostischen Reagenzien |
Also Published As
Publication number | Publication date |
---|---|
AU608294B2 (en) | 1991-03-28 |
EP0283327A2 (de) | 1988-09-21 |
AU1225088A (en) | 1988-08-10 |
DK513388D0 (da) | 1988-09-15 |
WO1988005440A1 (fr) | 1988-07-28 |
JP2002030099A (ja) | 2002-01-29 |
JPH07300498A (ja) | 1995-11-14 |
JP2004002421A (ja) | 2004-01-08 |
ES2104556T3 (es) | 1997-10-16 |
DE3855947D1 (de) | 1997-07-31 |
EP0283327A3 (de) | 1989-01-04 |
JPH11322792A (ja) | 1999-11-24 |
GR3024823T3 (en) | 1998-01-30 |
JP2948823B2 (ja) | 1999-09-13 |
EP0283327B1 (de) | 1997-06-25 |
JPH01502119A (ja) | 1989-07-27 |
JP2862810B2 (ja) | 1999-03-03 |
DK513388A (da) | 1988-11-16 |
ATE154808T1 (de) | 1997-07-15 |
DK174705B1 (da) | 2003-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3855947D1 (de) | Peptide mit den immunologischen Eigenschaften von HIV-2 | |
ATE64601T1 (de) | Lymphadenopathie-assoziierte huellenantigene und deren verwendungen. | |
MY103182A (en) | Vaccines against acquired immune deficiency syndrome. | |
DK0673948T3 (da) | Peptider, der stammer fra et retrovirus fra HIV-gruppen, og deres anvendelse | |
NZ220200A (en) | Hiv related peptides, antibodies to the peptides and vaccines therefrom | |
DE69011122T2 (de) | Rubella-e1 und c peptide. | |
EP0311228A3 (de) | Rekombinante Polypeptide und ihre Verwendung einschliesslich Nachweisverfahren für AIDS-Virus | |
DK0732339T3 (da) | Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf | |
CA2141670A1 (en) | Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus | |
DK0439601T3 (da) | Præparat indeholdende en B-epitop fra kappe- glycoproteinet fra et retrovirus og en T-epitop fra et protein, der er forskelligt fra dette retrovirus | |
EP0250128A3 (de) | Von AIDS-Patienten isoliertes Virus | |
DE69921589D1 (de) | Peptide zum Nachweis von HIV-1-Guppe O | |
DK284389A (da) | Precursorantigener | |
OA08716A (fr) | Peptides susceptibles d'être reconnus par des anticorps induits contre des retrovirus d'immunodéficience humaine (virus HIV), leurs applications au diagnostic des infections dues à certains de ces virus et, le cas échéant, à la vaccination contre le sida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |